Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guoxin Wu

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
The Journal of Clinical Investigation|April 15, 2022
Combined noncanonical NF-κB agonism and targeted BET bromodomain inhibition reverse HIV latency ex vivoShane D Falcinelli, Jackson J Peterson, Anne-Marie W Turner, et al.
Science Translational Medicine|April 20, 2018
CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cellsMohamed Abdel-Mohsen, Leticia Kuri-Cervantes, Judith Grau-Exposito, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 16, 2008
First demonstration of cerebrospinal fluid and plasma A beta lowering with oral administration of a beta-site amyloid precursor protein-cleaving enzyme 1 inhibitor in nonhuman primatesSethu Sankaranarayanan, Marie A Holahan, Dennis Colussi, et al.
Research Square|April 1, 2025
TGF-β mediates epigenetic control of innate antiviral responses and SIV reservoir sizeKhader Ghneim, Felipe Ten-Caten, Ana Carolina Santana, et al.
Nature Immunology|March 21, 2026
TGF-β mediates epigenetic control of innate antiviral responses and SIV reservoir sizeKhader Ghneim, Felipe Ten-Caten, Ana Carolina Santana, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
The Journal of Clinical Investigation|April 15, 2022
Combined noncanonical NF-κB agonism and targeted BET bromodomain inhibition reverse HIV latency ex vivoShane D Falcinelli, Jackson J Peterson, Anne-Marie W Turner, et al.
Science Translational Medicine|April 20, 2018
CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cellsMohamed Abdel-Mohsen, Leticia Kuri-Cervantes, Judith Grau-Exposito, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 16, 2008
First demonstration of cerebrospinal fluid and plasma A beta lowering with oral administration of a beta-site amyloid precursor protein-cleaving enzyme 1 inhibitor in nonhuman primatesSethu Sankaranarayanan, Marie A Holahan, Dennis Colussi, et al.
Research Square|April 1, 2025
TGF-β mediates epigenetic control of innate antiviral responses and SIV reservoir sizeKhader Ghneim, Felipe Ten-Caten, Ana Carolina Santana, et al.
Nature Immunology|March 21, 2026
TGF-β mediates epigenetic control of innate antiviral responses and SIV reservoir sizeKhader Ghneim, Felipe Ten-Caten, Ana Carolina Santana, et al.
Pageof 8